We are excited to announce that NeoMega36® has officially made its way to Norway! This marks the sixth country where our innovative solution is now in use, and we couldn’t be happier to welcome our first Norwegian customer. Expanding into new markets is an important… Read More »NeoMega36® has reached Norway
We attended the West Midlands Neonatal Network Mortality Event at the Walsall Manor Hospital in Walsall, UK. The neonatal network includes 15 hospitals and it was a great opportunity to come out and meet current customers, but also speaking to new clinicians. Team Neobiomics was… Read More »West Midlands Perinatal Mortality Event
🎄✨ Merry Christmas from All of Us at Neobiomics! ✨🎄 As the holiday season fills the air with joy and warmth, we want to take a moment to express our heartfelt gratitude to our valued customers, partners, and colleagues. 2024 has been a year of… Read More »Merry Christmas From Neobiomics
From Dec 5 to Dec 8, 2024, Neobiomics attended the 9th International Neonatology Association Conference (INAC) in Berlin, Germany. About 350 participants attended the conference, and our representative was Frank Alkenbrecher. The congress included a very international group of physicians, including participants from the USA,… Read More »International Neonatal Association Conference 2024
We are thrilled to share that we have successfully shipped our first ProPrems® order to Estonia! Expanding into new territories marks an exciting milestone, and we’re proud of this latest partnership. We eagerly look forward to strengthening this collaboration and establishing connections with new partners.… Read More »ProPrems® in use in Estonia